We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Judge Gives Par Pharma Shareholders 2nd Chance

Law360 (June 25, 2008, 12:00 AM EDT) -- Shareholders have 30 days to amend securities fraud claims against Par Pharmaceutical Co. Inc. and its top executives after a judge threw out their consolidated class action complaint on Tuesday.

New Jersey District Judge Peter Sheridan granted the drugmaker's motion to dismiss the lawsuit, saying the shareholders relied on generalized allegations based on the officers' positions in the company.

The shareholders, who sued Par and four executives after the company announced it would have to restate its reported revenues by $55 million, did not meet the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.